The observed increase in Bdnf expression in the mPFC and the HPP of A53T+ mice could be misinterpreted as a compensatory mechanism aimed at mitigating the early effects of α-synuclein toxicity, as similar findings were reported in other models of PD (e.g., [84]). The gene discussed is BDNF; the disease is Parkinson disease.